-+ 0.00%
-+ 0.00%
-+ 0.00%

INNOVENT BIOLOGICS: ARCOTATUG TAVATECAN DEMONSTRATED FAVORABLE SAFETY PROFILE, WITH A LOW INCIDENCE OF GASTROINTESTINAL ADVERSE EVENTS

Reuters·10/23/2026 12:00:01

Please log in to view news